Logo image of HTFL

HEARTFLOW INC (HTFL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HTFL - US42238D1072 - Common Stock

28.935 USD
+0.93 (+3.34%)
Last: 12/4/2025, 8:27:44 PM
28.935 USD
0 (0%)
After Hours: 12/4/2025, 8:27:44 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HTFL. HTFL was compared to 35 industry peers in the Health Care Technology industry. HTFL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, HTFL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HTFL had negative earnings in the past year.
HTFL Yearly Net Income VS EBIT VS OCF VS FCFHTFL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of HTFL (-60.51%) is worse than 82.86% of its industry peers.
Industry RankSector Rank
ROA -60.51%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTFL Yearly ROA, ROE, ROICHTFL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 500 1K

1.3 Margins

HTFL has a better Gross Margin (75.07%) than 80.00% of its industry peers.
The Profit Margin and Operating Margin are not available for HTFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HTFL Yearly Profit, Operating, Gross MarginsHTFL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

HTFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HTFL remains at a similar level compared to 1 year ago.
The debt/assets ratio for HTFL is higher compared to a year ago.
HTFL Yearly Shares OutstandingHTFL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M
HTFL Yearly Total Debt VS Total AssetsHTFL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -3.55, we must say that HTFL is in the distress zone and has some risk of bankruptcy.
HTFL has a worse Altman-Z score (-3.55) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.55
ROIC/WACCN/A
WACC9.7%
HTFL Yearly LT Debt VS Equity VS FCFHTFL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M -50M 100M

2.3 Liquidity

HTFL has a Current Ratio of 3.60. This indicates that HTFL is financially healthy and has no problem in meeting its short term obligations.
HTFL has a better Current ratio (3.60) than 80.00% of its industry peers.
HTFL has a Quick Ratio of 3.60. This indicates that HTFL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HTFL (3.60) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
HTFL Yearly Current Assets VS Current LiabilitesHTFL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 50M 100M

More info and screens

4

3. Growth

3.1 Past

HTFL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.04%, which is quite impressive.
The Revenue has grown by 44.32% in the past year. This is a very strong growth!
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

HTFL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.98% yearly.
Based on estimates for the next years, HTFL will show a very strong growth in Revenue. The Revenue will grow by 27.68% on average per year.
EPS Next Y11.31%
EPS Next 2Y18.27%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue Next Year34.51%
Revenue Next 2Y29.45%
Revenue Next 3Y27.68%
Revenue Next 5YN/A

3.3 Evolution

HTFL Yearly Revenue VS EstimatesHTFL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
HTFL Yearly EPS VS EstimatesHTFL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HTFL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HTFL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HTFL Price Earnings VS Forward Price EarningsHTFL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HTFL Per share dataHTFL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

HTFL's earnings are expected to grow with 18.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.27%
EPS Next 3Y18.98%

More info and screens

0

5. Dividend

5.1 Amount

HTFL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTFLOW INC

NASDAQ:HTFL (12/4/2025, 8:27:44 PM)

After market: 28.935 0 (0%)

28.935

+0.93 (+3.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)N/A N/A
Inst Owners27.97%
Inst Owner ChangeN/A
Ins Owners20.87%
Ins Owner Change39.22%
Market Cap2.46B
Revenue(TTM)125.81M
Net Income(TTM)-96.43M
Analysts81.82
Price Target39.37 (36.06%)
Short Float %1.33%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.03%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.48
BVpS-1.48
TBVpS-1.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -60.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -3.55
F-ScoreN/A
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y11.31%
EPS Next 2Y18.27%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue 1Y (TTM)44.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year34.51%
Revenue Next 2Y29.45%
Revenue Next 3Y27.68%
Revenue Next 5YN/A
EBIT growth 1Y16.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.7%
EBIT Next 3Y15.76%
EBIT Next 5YN/A
FCF growth 1Y11.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.72%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTFLOW INC / HTFL FAQ

What is the ChartMill fundamental rating of HEARTFLOW INC (HTFL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to HTFL.


What is the valuation status of HEARTFLOW INC (HTFL) stock?

ChartMill assigns a valuation rating of 0 / 10 to HEARTFLOW INC (HTFL). This can be considered as Overvalued.


What is the profitability of HTFL stock?

HEARTFLOW INC (HTFL) has a profitability rating of 1 / 10.


How financially healthy is HEARTFLOW INC?

The financial health rating of HEARTFLOW INC (HTFL) is 3 / 10.